Wound management involves an understanding of the aetiology and pathophysiology of a wound, the healing process and how best to manage both. Acute wounds can occur suddenly, such as burns and skin tears. Chronic wounds fail to progress through the normal stages of healing and can include ulcers, pressure injuries and infected wounds.

Dressings and bandages provide the optimal environment for the healing of all wound types. It is important for healthcare practitioners to understand the key differences in their properties, uses and precautions. Selecting the ideal dressing or bandage can minimise the healing duration, reduce the bioburden, and improve a patient's quality of life.



The prevalence of wounds continues to increase because of the ageing population, rising incidence of diabetes and respiratory diseases, and poor nutrition. The skill of identifying and treating wounds grows with our understanding and knowledge of the processes of wound repair and healing. There are many types of wound treatments available. This often causes confusion and the misuse of products.

On any given day in Australia, around 500,000 people have an unhealed wound, and the annual financial impact is more than $3 billion. These costs are both direct, in terms of wound treatment, and indirect such as the impact on the ability to work. Cost savings can be achieved by appropriate wound management.1-3

Over the last 50 years, the emphasis has been on developing a range of wound dressings with properties of absorption, hydration and antimicrobial activity. Wound care has seen a shift from simple dressings to devices and products that incorporate pharmaceutically active ingredients.4 Current and future treatments include biologicals, topical immunosuppressants, growth factors and various types of tissue matrices.



The ageing process affects most structures of the skin. The skin loses hair follicles, sebaceous glands that supply natural moisture to the skin, receptors (including those for touch, pressure, pain and temperature), blood supply and sweat glands. As a result, the skin becomes thinner, more brittle, avascular and more prone to injury.5

Comorbidities and various intrinsic and extrinsic factors significantly affect wound healing (see Box 1).6

Box 1 - Factors that affect wound healing

Intrinsic factors

  • health status
  • immune function
  • age
  • extremes of body mass
  • diabetes
  • nutritional status

Extrinsic factors

  • mechanical stress
  • debris
  • temperature
  • drying or maceration
  • infection
  • chemical stress
  • other factors (e.g. smoking, drugs)

Assessing the patient and wound is critical to facilitate an accurate diagnosis and thus an appropriate management strategy. The main issues to consider are the wound type, wound position, wound shape, level and type of exudate, presence of any comorbidities, drugs being used, nutritional state and known investigations.

There are several tools that can be used as part of the assessment including the TIME and MEASURE frameworks (see Box 2).7,8,9 These allow clinicians to consider a wide range of factors relating to the wound and patient.8,9

Box 2 - Assessment tools

TIME framework7

  • Tissue
  • Infection
  • Moisture balance
  • wound Edge

MEASURE framework8

  • Measure (length, width, depth and area)
  • Exudate (quantity and quality)
  • Appearance (wound bed, including tissue type and amount)
  • Suffering (pain type and level)
  • Undermining (presence or absence)
  • Re-evaluate (monitoring of all parameters regularly)
  • Edge (condition of edge and surrounding skin)


General principles

The management of any wound involves addressing the cause of the wound and the use of dressings or bandages. Wound dressings can be divided into two broad groups - inert/passive and interactive/bioactive.

Inert dressings fulfil very few of the properties of an ideal dressing and can be subclassified into absorbent and non-absorbent. They include gauze, lint, non-adherent dressings and tulle dressings. They have limited (if any) use as primary dressings (which are applied directly on the wound), but some are useful as secondary dressings (which are used on top of primary dressings).

Interactive dressings alter the wound environment and interact with the wound surface to optimise healing. Interactive dressings can be absorbent, non-absorbent or moisturising. They include films, hydrocolloids, foams, hydrogels and hydroactive dressings. They have the properties of protection, absorption, hydration, antimicrobial action and tissue modulation.

When instructing a patient or their family or carers on the use of dressings, remember to keep it simple to increase the likelihood that a product will be used correctly.


Acute wounds

Acute wounds occur suddenly and can include burns, lacerations, grazes and skin tears.10


The main aims of burn management are to prevent infection, reduce pain and provide an ideal wound-healing environment. It is important to identify the type, depth and area of a burn.11,12

Many burn injuries are superficial. They involve pain, discomfort and disruption to a patient’s routine activities of daily living. Most superficial burns involve only the top layer of the skin. These burns do not form blisters and generally heal in 3–6 days without scarring. The superficial burns requiring specialist care are typically in patients who are immunosuppressed. The essential management of a superficial burn involves the immediate application of cold running tap water for 20–30 minutes, but not ice, as temperatures below 5 °C may deepen burns. This is followed by the use of silver dressings or amorphous or sheet hydrogels.13 The use of topical silver-containing treatments has shifted from creams to metallic silver dressings. The use of a topical silver cream on a mucous surface will result in the formation of a mucilaginous slime on the surface of the tissue, which is cytotoxic and slows healing.

Deep burns, on the other hand, are associated with scarring, functional defects, psychological problems, costs to the community and contractures. Deep burns involve damage to the dermis and subcutis. It is essential to assess the cause of and extent of damage associated with deep burns. Management involves infection prevention, debridement and grafting.

Skin tears

As a result of skin ageing and the epidermal layer separating more easily from the dermis with age, skin tears are common in older people. The main cause is trauma from manual handling (e.g. transferring a patient from a bed to a chair, removing adhesive tapes, falls, and collisions with bed rails and wheelchair foot plates).

If possible, align the skin back in place, secure with adhesive skin strips, such as Steri-Strips, and cover with a silicone foam dressing. If there is a loss of the epidermis, cover the area of loss with a silicone tulle before the application of a silicone foam dressing.

In addition to treatment, it is essential to identify the risk of recurrence and introduce a plan for prevention. The use of an effective moisturiser twice a day can reduce the risk of skin tears significantly.14,15


Chronic wounds

A chronic wound is described as an acute wound that has not healed after six weeks. Chronic wounds fail to progress through the normal stages of healing and can include venous leg ulcers, pressure injuries, diabetic foot ulcers, neoplasia, and atypical wounds such as vasculitis.10

If you are treating a chronic wound and observe no improvement after four weeks of management, it is then essential to reassess and consider a biopsy or referral to a specialist wound clinic. It is important to note that a non-healing wound can become neoplastic.

Venous ulcers

Venous leg ulcers are the most common ulcers. The cause is valve incompetence, with consequent venous hypertension forcing fluid into tissues, producing hypoxia at the periphery. The initial wound is often traumatic, with poor healing due to the presence of hypoxic tissue. The main features include oedema, staining due to haemosiderin deposition, lipodermatosclerosis, presentation in the lower third of the leg, an often-painless presentation, an irregular shape and the potential for copious exudate.

It is important to perform a vascular assessment to identify a clear venous pathology and check the arterial system to ensure that compression is safe. Other aspects of the wound can be addressed with specific dressings placed under the compression (see Table 1).4,10,16-18

If a venous pathology is confirmed, apply graduated compression bandages or stockings to the ulcers (see Table 2). There are different grades of stockings available to provide different pressures. The minimum coverage should be from the toes to the knee, with a compression pressure of 30-40 mmHg at the ankles.18

Table 1 - Wound dressings 4,10,16-18

Product Classification Properties Uses Precautions
Paraffin gauze
(e.g. Jelonet)
Protects new tissue growth Atraumatic to surrounding skin Conformable to wound bed Low- to high-exuding wounds Primary dressing over superficial low-exuding wounds No longer used due to shedding of fibres and being open weave
(e.g. Cuticerin, Adaptic, Atrauman)
Provides a protective layer May dry out if left in place for too long
(e.g. Mepitel)
Contact layer is soft silicone Wounds in patients with fragile skin Consider allergies to soft silicone adhesives
Non-adherent dressings
(e.g. Melolin, Cutilin)
Cotton wool with plastic surface Very low absorption Primary dressing over superficial low-exuding wounds Will not cope with moderate or high levels of exudate
High absorption
(e.g. Mesorb, Vliwasorb, Zetuvit)
Polymers Highly absorbent Moderate- to high-exuding wounds Secondary dressing over exuding wounds Do not use on dry or low-exuding wounds
Film dressings
(e.g. Opsite, Tegaderm) Polyurethane film Moisture control Breathable bacterial barrier Transparent (allows for visualisation of the wound) Primary dressing over superficial low-exuding wounds Secondary dressing over alginate or hydrogel primary dressing Do not use on patients with fragile or compromised surrounding skin Do not use on moderate- to high-exuding wounds
Hydrocolloid dressings
(e.g. DuoDERM, Comfeel) Absorb low to moderate levels of fluid Promote autolytic debridement Clean, low- to moderate-exuding wounds Do not use on dry or necrotic wounds or high-exuding wounds May encourage overgranulation May cause maceration Do not use on diabetic wounds
Foam dressings
(e.g. Lyofoam Max, Allevyn)
Fluid absorption Moisture control Conformable to wound bed Thermal insulation Cushioning Moderate- to high-exuding wounds Low- to non-adherent products available for patients with fragile skin Do not use on dry or necrotic wounds or those with minimal exudate
Soft silicone
(e.g. Mepilex, Allevyn Life)
Non-adherent Wounds in patients with fragile skin Pressure prevention Consider allergies to soft silicone adhesives
Hydroactive dressings
Foam like
(e.g. Biatain, Tielle)
Fluid absorption Moisture control Conformable to wound bed Similar but not the same as foam dressings Moderate- to high-exuding wounds Products available for cavity wounds Low-adherent products available for patients with fragile skin Do not use on dry or necrotic wounds or those with minimal exudate
Alginate dressings
(e.g. Kaltostat, Algisite M)
Fluid absorption Promote autolytic debridement Moisture control Conformable to wound bed Some products are haemostatic Moderate- to high-exuding wounds Products in the form of ropes available for cavity wounds Products available with silver for antimicrobial activity Do not use on dry or necrotic wounds Use with caution on friable tissue (may cause bleeding) Do not pack cavity wounds tightly
Hydrogel dressings
Sterile amorphous
(e.g. Intrasite, Purilon)
Rehydrate wound bed Moisture control Promote autolytic debridement Cooling Provide pain relief Dry and low- to moderate-exuding wounds and superficial burns Products available with antimicrobials Do not use on high-exuding wounds or where anaerobic infection is suspected May cause maceration
Preserved amorphous
(e.g. Solugel, Solosite)
(e.g. Hydrotac Transparent)
Antimicrobial dressings
Iodine Effective against bacteria, mycobacteria, fungi, protozoans, spores and viruses - no evidence of resistance to iodine Debrider Some products stimulate wound healing Critically colonised wounds or wounds with clinical signs of infection Low- to high-exuding wounds Diabetic wounds Consider sensitivity to iodine Short-term use recommended (e.g. 3 months) to minimise risk of systemic absorption
Cadexomer iodine
(e.g. Iodosorb)
Polyethylene glycol iodine
(e.g. Inadine)
(e.g. Acticoat, Mepilex Ag, Aquacel Ag, Biatain Ag)
Effective against a broad range of bacteria, fungi and viruses Critically colonised wounds or wounds with clinical signs of infection Low- to high-exuding wounds Products available with foam and alginates or carboxymethylcellulose for increased absorption Some products may cause discolouration Consider sensitivity to silver Discontinue after 2 weeks if no improvement and re-evaluate
Polyhexamethylene biguanide (PHMB)
(e.g. Prontosan)
Newer non-toxic products Effective against a broad range of bacteria, fungi and viruses Sloughy, low- to moderate-exuding wounds Critically colonised wounds or wounds with clinical signs of infection Do not use on clean, granulating wounds
Dialkylcarbamoyl chloride (DACC)
(e.g. Sorbact)
Hypochlorous acid
(e.g. Microdacyn)
Enzymatic alginate gel
(e.g. Flaminal)
Miscellaneous dressings
Sucrose octasulfate
(e.g. UrgoStart)
Controls wound protease levels Stimulates wound healing Clean wounds that are not progressing despite correction of underlying causes, exclusion of infection and optimal wound care Do not use on dry wounds or those with leathery eschar

Table 2 - Bandages and stockings

Type Uses Examples of products
Crepe bandage Limited Handycrepe
Light cohesive bandage Dressing retention Handy Gauze Cohesive, Peha-haft
Light tubular bandage Dressing retention, limb protection Tubifast
Elastic cohesive bandage Limb support, compression Coban, Co-Plus
Compression bandage
  • high stretch
  • short stretch
Venous disease
Tensopress, SurePress, Setopress
Comprilan, Lastolan
Compression multiple-layer bandage Venous disease Coban 2, Profore
Compression wraps Venous disease Venosan, JOBST, Sigvaris
Compression stockings Venous disease, deep vein thrombosis prevention Venosan, JOBST, Sigvaris

Arterial ulcers

Arterial ulcers result from reduced arterial blood flow. The features include claudication, pain at rest, a reduction in the ankle brachial index score, weak or absent pedal pulses and sluggish or poor capillary refill. The wounds are regular in outline with a punched-out appearance, and the ulcer site is usually at or below the ankles.

The acute management of arterial ulcers usually involves improving blood flow through angioplasty, stenting or bypass grafting and, if necessary, the amputation of a digit or limb. Pain management is often necessary.16

Diabetic foot ulcers

Diabetic wounds can be classified as either neuropathic, ischaemic or neuroischaemic. Neuropathic wounds are painless and thus often unnoticed, occur over bony prominences or areas of pressure, and will heal with a sufficient blood supply. Ischaemic wounds are painful and not necessarily in areas of pressure. A poor blood supply negatively affects healing. Neuroischaemic wounds involve the loss of both sensation and arterial blood supply.

Optimising glycaemic control is critical for management. The main management issues are ensuring that the circulation is adequate, that any infection is controlled and that pressure is removed. It is essential to involve a multidisciplinary team including an orthotics specialist and podiatrist in the management of diabetic foot ulcers. Treatment will often involve antimicrobial dressings and pressure off-loading. Pressure off-loading refers to reducing or removing weight placed on the feet, which is achieved using felt devices and specialised footwear that are provided by podiatrists. There is a new treatment containing sucrose octasulfate with strong evidence for its use.19,20

Management should involve regular review and examination of the patient. It should also involve education of the patient, their family or carers and healthcare providers, as well as appropriate footwear and the treatment of non-ulcerative pathology.19,21,22 These include changes in the skin and nails, such as plantar erythema, xerosis (dry skin), fungal toe infections and dystrophic nails.

The ongoing risk of foot ulcers includes the impact of sensory loss, which can be assessed by daily inspections of the feet for blisters, fissures, bleeding or lesions such as tinea between the toes. Treatment of dry skin and lesions, and the removal of calluses caused by autonomic neuropathy are important.

Pressure injuries

Pressure injuries are a frequent problem for patients in hospital and residential aged-care facilities. When pressure of more than 30 mmHg is applied over bony prominences, this physically closes off small vessels, resulting in hypoxic tissue and ischaemic injury. Pressure injuries may also be caused by friction or shear forces.

It is important to identify patients at risk using screening tools, such as the Norton or Braden scales, and to manage risk factors. Skin damage in the sacral region can also be caused by incontinence-associated dermatitis, but this is not classified as a pressure injury. The main management strategy involves off-loading, dressings, improving nutrition if necessary, and the use of pressure-reducing surfaces on beds and chairs.23–27


Wound infection

Infection is a major factor in delaying wound healing. However, most chronic wounds have bacteria present on the surface, but they are not necessarily infected.

Tissue biopsy is the most accurate method of identifying an infection. Do not swab chronic wounds routinely, as this often leads to unnecessary antibiotic use and does not address the underlying problem. However, if a swab is to be used, the Levine method is preferred, described as follows. The wound should be cleaned with water or saline, not an antimicrobial solution. Following this, identify 1-2 cm of clean wound tissue. Rotate the applicator for five seconds while applying sufficient pressure to produce fluid from the wound tissue. Do not obtain a specimen from exudate, eschar or necrotic material.

Infected chronic wounds are more often due to the presence of anaerobes. For localised wound infections, use topical antimicrobials (e.g. polyhexamethylene biguanide (PHMB), octenidine dihydrochloride, chlorhexidine, povidone-iodine). For systemic or spreading infections, systemic antimicrobials are required in combination with topical antimicrobial therapies; the choice of systemic antimicrobial should be based on identification of the causative organism and its susceptibilities.28

Biofilms have been described as an aggregate microorganism with unique characteristics and enhanced tolerance to treatment and the host defences. Wound biofilms are associated with impaired wound healing and signs and symptoms of chronic inflammation. Systemic antimicrobials in general do not penetrate biofilms and management involves debridement and the use of products such as cadexomer iodine.28

The bioburden refers to the number of microorganisms in a wound, the pathogenicity of which is influenced by the microorganisms present (i.e. the species and strain), their growth and their potential virulence mechanisms.2 The major roles for antimicrobial dressings in wound management are to reduce the bioburden in acute and chronic wounds that are infected or are prevented from healing by microorganisms, and to act as an antimicrobial barrier for acute and chronic wounds at high risk of infection or reinfection.28,29 Types of antimicrobial dressings are listed in Table 1.


Wound dressings

Dressings provide the best environment for wound healing in combination with the management of the cause of the wound and factors impacting healing. Table 1 lists the different dressings that are available. The general rules for dressings are as follows:

  • allow 2-3 cm of dressing greater than the size of the wound
  • place a third of the dressing above and two-thirds below the wound
  • remove dressing when strikethrough occurs
  • remove dressing with care in older patients
  • do not pre-moisten alginate dressings
  • no single dressing will meet all the requirements.



There are three main roles for a bandage: keeping a dressing in place, supporting an injured joint and assisting venous return by compression. Table 2 lists the different types of bandages and their uses.

Compression is the major management strategy for venous disease, and this can be provided with the use of bandages, stockings and wraps. Before applying compression to the legs, it is essential to confirm sufficient arterial circulation.30

Crepe bandages are not appropriate for the management of venous leg ulcers and have little use for dressing retention. Light cohesive or tubular bandages are the most appropriate and cost effective for dressing retention.



The Wounds Australia website has guidelines on Prevention and Management of Venous Leg Ulcers, Prevention and Treatment of Pressure Ulcers Injuries, Aseptic Technique in Wound Dressing Procedure, Atypical Wounds - Best Clinical Practices and Challenges, and Wound Infection in Clinical Practice: Principles of Best Practice.

The Department of Veterans' Affairs website has a wound care module with a wound identification and product selection chart available to download.



Wounds present with unique characteristics and needs. The decision to treat wounds should be based on a sound knowledge of the patient, underlying cause and goal of management. Wound management is not simply applying a dressing. It involves an accurate diagnosis of the underlying cause and treating this cause. A dressing manages the wound environment, not the cause.

Conflicts of interest: none declared

This article is peer-reviewed.


Australian Prescriber welcomes Feedback.



  1. Pacella RE, Tulleners R, Cheng Q, Burkett E, Edwards H, Yelland S, et al. Solutions to the chronic wounds problem in Australia: a call to action. Wound Pract Res 2018;26:84-98. [cited 2023 Jul 1]
  2. McCosker L, Tulleners R, Cheng Q, Rohmer S, Pacella T, Graves N, et al. Chronic wounds in Australia: a systematic review of key epidemiological and clinical parameters. Int Wound J 2019;16:84-95.
  3. Vua T, Harris A, Duncan G, Sussman G. Cost-effectiveness of multidisciplinary wound care in nursing homes: a pseudo-randomized pragmatic cluster trial. Fam Pract 2007;24:372-9.
  4. Ahangar P, Woodward M, Cowin AJ. Advanced wound therapies. Wound Pract Res 2018;26:58-68. [cited 2023 Jul 1]
  5. Gosain A, DiPietro LA. Aging and wound healing. World J Surg 2004;28:321-6.
  6. Anderson K, Hamm RL. Factors that impair wound healing. J Am Coll Clin Wound Spec 2014;4:84-91.
  7. Schultz GS, Barillo DJ, Mozingo DW, Chin GA. Wound bed preparation and a brief history of TIME. Int Wound J 2004;1:19-32.
  8. Keast DH, Bowering CK, Evans AW, Mackean GL, Burrows C, D’Souza L. MEASURE: a proposed assessment framework for developing best practice recommendations for wound assessment. Wound Repair Regen 2004;12(Suppl 3): S1-17.
  9. Leaper DJ, Schultz G, Carville K, Fletcher J, Swanson T, Drake R. Extending the TIME concept: what have we learned in the past 10 years. Int Wound J 2012;9(Suppl 2):1–19.
  10. Sussman G. Ulcer dressings and management. Aust Fam Physic 2014;43:588-92. [cited 2023 Jul 1]
  11. Cuttle L, Pearn J, McMillan JR, Kimble RM. A review of first aid treatments for burn injuries. Burns 2009;35:768-75.
  12. Hettiaratchy S, Papini R. Initial management of a major burn: I-overview. BMJ 2004;328:1555.
  13. Kempf M, Kimble RM, Cuttle L. Cytotoxicity testing of burn wound dressings, ointments and creams: a method using polycarbonate cell culture inserts on a cell culture system. Burns 2011;37:994-1000.
  14. Sussman G, Golding M. Skin tears: should the emphasis be only their management? Wound Pract Res 2011;19:66-71. [cited 2023 Jul 1]
  15. Carville K, Leslie G, Osseiran-Moisson R, Newall N, Lewin G. The effectiveness of a twice-daily skin-moisturising regimen for reducing the incidence of skin tears. Int Wound J 2014;11:446-53.
  16. Mostow EN. Diagnosis and classification of chronic wounds. Clin Dermatol 1994;12:3-9.
  17. Weller CD, Team V, Sussman G. First-line interactive wound dressing update: a comprehensive review of the evidence. Front Pharmacol 2020;11:155.
  18. Cheng Q, Gibb M, Graves N, Finlayson K, Pacella RE. Cost-effectiveness analysis of guideline based optimal care for venous leg ulcers in Australia. BMC Health Serv Res 2018;18:421.
  19. Edmonds M, Lázaro-Martínez JL, Alfayate-García JM, Martini J, Petit J-M, Rayman G, et al. Sucrose octasulfate dressing versus control dressing inpatients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabet Endocrinol 2018;6:186-96.
  20. Chen P, Carville K, Swanson T, Lazzarini PA, Charles J, Cheney J, et al. Australian guideline on wound healing interventions to enhance healing of foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease. J Foot Ankle Res 2022;15:40.
  21. Wu SC, Driver VR, Armstrong DG. Vascular problems in the diabetic foot. J Vasc Ultrasound 2015;39:39-48.
  22. Reardon R, Simring D, Kim B, Mortensen J, Williams D, Leslie A. The diabetic foot ulcer. Aust J Gen Pract 2020;49:250-5.
  23. Lyder CH. Pressure ulcer prevention and management. JAMA 2003;289:223-6.
  24. European Pressure Ulcer Advisory Panel, National Pressure Injury Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and treatment of pressure ulcers/injuries: quick reference guide. Emily Haesler (editor). EPUAP/NPIAP/PPPIA; 2019. [cited 2023 Jul 1]
  25. Campbell JL, Coyer FM, Osborne SR. Incontinence- associated dermatitis: a cross-sectional prevalence study in the Australian acute care hospital setting. Int Wound J 2016;13:403-11.
  26. Frehner E, Watts R; Wound Healing and Management Node Group. Evidence summary: wound management — hydrogel dressings without additional therapeutic additives. Wound Pract Res 2016;24:59-60. [cited 2023 Jul 1]
  27. Pancorbo-Hidalgo PL, Garcia-Fernandez FP, Lopez-Medina IM, Alvarez-Nieto C. Risk assessment scales for pressure ulcer prevention: a systematic review. J Adv Nurs 2006;54:94-110.
  28. International Wound Infection Institute (IWII). Wound infection in clinical practice: principles of best practice. 3rd ed. London: Wounds International; 2022. [cited 2023 Jul 1]
  29. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008;8:43.
  30. Rotsch C, Oschatz H, Schwabe D, Weiser M, Möhring U. 22 - Medical bandages and stockings with enhanced patient acceptance. In: Bartels VT. Handbook of medical textiles. Oxford: Woodhead Publishing; 2011. p. 481-504.
Creative Commons License

Geoffrey Sussman

Associate professor, Faculty of Medicine, Nursing and Health Sciences, Monash University